We are live on ! Find out more
CYTK icon

Cytokinetics

109 hedge funds and large institutions have $187M invested in Cytokinetics in 2016 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 39 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

257% more call options, than puts

Call options by funds: $4.27M | Put options by funds: $1.2M

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

13% less funds holding

Funds holding: 125109 (-16)

23% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 39

32% less capital invested

Capital invested by funds: $276M → $187M (-$89.1M)

52% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 31

Holders
109
Holders Change
-16
Holders Change %
-12.8%
% of All Funds
2.9%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
15
Increased
30
Reduced
39
Closed
31
Calls
$4.27M
Puts
$1.2M
Net Calls
+$3.07M
Net Calls Change
-$93K
Name Holding Trade Value Shares
Change
Change in
Stake
Balyasny Asset Management
26
Balyasny Asset Management
Illinois
$1.25M -$408K -55,871 -24%
IHM
27
Iguana Healthcare Management
New York
$1.23M -$1.28M -175,000 -50%
IIM
28
Ironwood Investment Management
Massachusetts
$1.23M -$553K -75,700 -30%
USAA
29
United Services Automobile Association
Texas
$1.16M +$1.2M +164,060 New
BIM
30
BlackRock Investment Management
Delaware
$902K +$6.82K +933 +0.7%
PAI
31
Palo Alto Investors
California
$872K
BA
32
BlackRock Advisors
Delaware
$872K +$11K +1,502 +1%
TCIM
33
TIAA CREF Investment Management
New York
$867K -$851K -116,538 -49%
TC
34
TFS Capital
Pennsylvania
$860K +$891K +122,027 New
TI
35
Trexquant Investment
Connecticut
$792K +$821K +112,403 New
Deutsche Bank
36
Deutsche Bank
Germany
$772K +$218K +29,805 +37%
Millennium Management
37
Millennium Management
New York
$718K -$2.03M -277,691 -73%
Two Sigma Investments
38
Two Sigma Investments
New York
$711K -$1.6M -219,570 -69%
SIM
39
Spark Investment Management
New York
$708K -$312K -42,700 -30%
HVC
40
Healthcare Value Capital
New Jersey
$705K
Asset Management One
41
Asset Management One
Japan
$621K
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$583K -$255K -34,900 -30%
CAM
43
ClariVest Asset Management
California
$544K -$173K -23,728 -23%
ARTA
44
A.R.T. Advisors
New York
$530K -$70.1K -9,600 -11%
AI
45
Analytic Investors
California
$523K -$70.4K -9,631 -11%
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$522K -$68.7K -9,400 -11%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$518K +$67.1K +9,189 +14%
PPA
48
Parametric Portfolio Associates
Washington
$487K +$317K +43,405 +169%
Two Sigma Advisers
49
Two Sigma Advisers
New York
$474K -$83.2K -11,395 -14%
SO
50
STRS Ohio
Ohio
$422K

CYTK Hedge Fund Activity: Q1 2016 in Review

109 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q1 2016, worth a combined $187M — down 32% from $276M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of CYTK and 15 opened new positions — a net loss of 16 holders — while 39 trimmed existing stakes and 30 added.

The largest buyer was Wellington Management Group, adding an estimated $12.2M. The largest seller was Teachers Advisors, cutting an estimated $4.02M.

  • 109 institutional investors held Cytokinetics (CYTK) as of Q1 2016, down from 125 in Q4 2015.
  • Funds reported $187M of Cytokinetics stock for Q1 2016, down 32% quarter-over-quarter.
  • 15 funds opened new Cytokinetics positions in Q1 2016 and 31 closed out, a net change of -16 holders.
  • The largest Cytokinetics buyer in Q1 2016 was Wellington Management Group, an estimated $12.2M added.
  • The largest Cytokinetics seller in Q1 2016 was Teachers Advisors, an estimated $4.02M sold.

Based on aggregated 13F filings for Q1 2016.